Drug Markets/Desvenlafaxine Succinate

Desvenlafaxine Succinate

24 NDCs across 4 manufacturers|15 Generic,9 Brand

Desvenlafaxine Succinate is used to treat major depressive disorder, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Feb 29, 2008, and the first generic was approved Jun 29, 2015. FDA's Orange Book lists 31 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $67 million on Desvenlafaxine Succinate across 966,000 claims for 183,000 beneficiaries.

Desvenlafaxine Succinate is available as 24 NDCs from 4 manufacturers (15 generic, 9 brand), with NADAC prices from $0.40 to $13.97 per EAthe most expensive product costs about 35× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

24

15G / 9B

Manufacturers

4

competing in market

Price Spread

$0.40 – $13.97

per EA

7d Activity

3183 flat

avg -2.1% WoW · of 24 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

24 NDCs total, 24 shown

Drug Price 7d Change
PRISTIQ ER 25 MG TABLET
$13.9730
per EA
PRISTIQ ER 50 MG TABLET
$13.9564
per EA
-0.02%
PRISTIQ ER 50 MG TABLET
$13.9564
per EA
-0.02%
PRISTIQ ER 50 MG TABLET
$13.9564
per EA
-0.02%
PRISTIQ ER 100 MG TABLET
$13.9394
per EA
+0.02%
PRISTIQ ER 100 MG TABLET
$13.9394
per EA
+0.02%
PRISTIQ ER 100 MG TABLET
$13.9394
per EA
+0.02%
PRISTIQ ER 50 MG TABLET
$13.2311
per EA
PRISTIQ ER 100 MG TABLET
$12.8531
per EA
DESVENLAFAXINE SUCCNT ER 25 MG
$0.4116
per EA
-5.25%
DESVENLAFAXINE SUCCNT ER 25 MG
$0.4116
per EA
-5.25%
DESVENLAFAXINE SUCCNT ER 25 MG
$0.4116
per EA
-5.25%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 100 MG
$0.4069
per EA
-2.49%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%
DESVENLAFAXINE SUCCNT ER 50 MG
$0.3950
per EA
-2.35%

Frequently Asked Questions

What is Desvenlafaxine Succinate used to treat?

Desvenlafaxine Succinate is used to treat major depressive disorder, per the National Library of Medicine's MED-RT classification.

When did Desvenlafaxine Succinate become available as a generic?

FDA approved the first generic Desvenlafaxine Succinate (ANDA) on Jun 29, 2015. The Orange Book currently lists 31 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Desvenlafaxine Succinate?

In 2024, Medicare Part D spent $67 million on Desvenlafaxine Succinate across 966,000 claims for 183,000 beneficiaries.

How many Desvenlafaxine Succinate products are on the market?

The Desvenlafaxine Succinate drug market contains 24 NDCs from 4 manufacturers — 15 generic and 9 brand products.

What is the price range for Desvenlafaxine Succinate?

NADAC reference prices for Desvenlafaxine Succinate range from $0.3950 to $13.9730 per EA — the most expensive product costs about 35× the cheapest.

Is generic Desvenlafaxine Succinate cheaper than brand?

The average generic NADAC for Desvenlafaxine Succinate is $0.4031 per EA, versus $13.7494 for brand-labeled products — brand versions average about 34× the generic price.

Which manufacturers make Desvenlafaxine Succinate?

4 manufacturers list Desvenlafaxine Succinate in NADAC. Ranked by number of NDCs, the largest are Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. (9), Breckenridge Pharmaceutical Inc. (8), Macleods Pharmaceuticals Limited (4), Lupin Pharmaceuticals Inc. (3).

How has the price of Desvenlafaxine Succinate changed recently?

Over the past 7 days, 3 Desvenlafaxine Succinate NDCs rose and 18 fell, with a market-wide average change of -2.1%.